Tibor Glant to Chondroitin Sulfate Proteoglycans
This is a "connection" page, showing publications Tibor Glant has written about Chondroitin Sulfate Proteoglycans.
Connection Strength
0.586
-
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum. 2006 Aug; 54(8):2423-33.
Score: 0.276
-
Substrate specificity of 'elastomucoproteinase': an enzyme which can degrade cartilage aggrecan. Biochim Biophys Acta. 1993 Mar 26; 1162(3):266-74.
Score: 0.110
-
Experimental spondyloarthropathies: animal models of ankylosing spondylitis. Curr Rheumatol Rep. 2006 Aug; 8(4):267-74.
Score: 0.069
-
Genetic rescue of chondrodysplasia and the perinatal lethal effect of cartilage link protein deficiency. J Biol Chem. 2003 Oct 03; 278(40):39214-23.
Score: 0.055
-
Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum. 1997 Jun; 40(6):1037-45.
Score: 0.037
-
Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain. 2010 Aug; 133(Pt 8):2331-47.
Score: 0.023
-
Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol. 2000 Apr; 120(1):167-73.
Score: 0.011
-
Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts. Cancer Immunol Immunother. 1990; 32(2):137-42.
Score: 0.005